A research team from the BC-CfE, led by Kalysha Closson, Research Coordinator, Epidemiology and Population Health, recently studied the HIV prevention behaviour, including condom use, partner communication and refusal of unwanted sex, of adolescents in Soweto, South Africa.
Crystal meth has been identified in past research with acquiring HIV as it is associated with sexual practices that increase one’s likelihood of getting HIV.
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.
A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) – an HIV prevention drug recently made available at no charge to British Columbians at risk of HIV.
New research from the Momentum Health Study, a program supported by the BC Centre for Excellence in HIV/AIDS, finds rates of smoking are three times higher among gay and bisexual men compared to the general population in a province that has the lowest rates of smoking in the country.
Most people infected with Hep C do not experience any symptoms for decades. For those that do, the symptoms are often mild and flu-like, for example, feeing very tired, sore muscles, fever and nausea. These symptoms usually occur within 2 weeks to 6 months of exposure.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
